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Background: Inhalation of TIP peptides that mimic the lectin-like domain of TNF-α is a novel approach to attenuate
pulmonary oedema on the threshold to clinical application. A placebo-controlled porcine model of acute respiratory
distress syndrome (ARDS) demonstrated a reduced thermodilution-derived extravascular lung water index (EVLWI)
and improved gas exchange through TIP peptide inhalation within three hours. Based on these findings, the
present study compares a single versus a repetitive inhalation of a TIP peptide (TIP-A) and two alternate peptide
versions (TIP-A, TIP-B).
Methods: Following animal care committee approval ARDS was induced by bronchoalveolar lavage followed by
injurious ventilation in 21 anaesthetized pigs. A randomised-blinded three-group setting compared the single-
dosed peptide variants TIP-A and TIP-B as well as single versus repetitive inhalation of TIP-A (n = 7 per group). Over
two three-hour intervals parameters of gas exchange, transpulmonary thermodilution, calculated alveolar fluid
clearance, and ventilation/perfusion-distribution were assessed. Post-mortem measurements included pulmonary
wet/dry ratio and haemorrhage/congestion scoring.
Results: The repetitive TIP-A inhalation led to a significantly lower wet/dry ratio than a single dose and a small but
significantly lower EVLWI. However, EVLWI changes over time and the derived alveolar fluid clearance did not differ
significantly. The comparison of TIP-A and B showed no relevant differences. Gas exchange and ventilation/perfusion-
distribution significantly improved in all groups without intergroup differences. No differences were found in
haemorrhage/congestion scoring.
Conclusions: In comparison to a single application the repetitive inhalation of a TIP peptide in three-hour intervals
may lead to a small additional reduction the lung water content. Two alternate TIP peptide versions showed
interchangeable characteristics.
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Within the course of Acute Respiratory Distress Syn-
drome (ARDS) neutrophil accumulation and a develop-
ing, non-cardiogenic alveolar oedema represent early
pathophysiologic alterations, which are followed by an
impaired resolution of the accumulated fluid [1]. A
widespread array of aetiologies that induce endothelial* Correspondence: hartmane@uni-mainz.de
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unless otherwise stated.or alveolar epithelial damage can cause ARDS. This results
in increased microvascular permeability and disruption of
the alveolar-capillary unit with a consecutively impaired
ion and fluid transfer across the injured alveolar epithe-
lium [1-3]. Moreover, there is growing evidence that the
clearance of the oedema fluid by the lung itself is an
important factor in overcoming ARDS [4-7]. Tumor-
necrosis-factor-α (TNF-α) plays an important but dichoto-
mal role in early oedema formation: on the one hand
TNF-α promotes receptor-mediated inflammatory re-
sponse in injured lungs [8,9]. The receptor-independentral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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sible for beneficial effects: pulmonary application of TIP
peptides mimicking this lectin-like domain increases
oedema reabsorption via sodium transfer across the alveo-
lar epithelium and also reduces microvascular permeabil-
ity, which prevents further oedema formation [10-13].
The lectin-like domain therefore represents a novel ap-
proach in pharmacologic treatment of ARDS [3].
An application of a TNF-α derived TIP peptide (TIP-
A) led to a sustained reduction of the lung water content
in previous studies [10,12,14], though a repetitive appli-
cation has not yet been examined in vivo. An alternate,
synthetic version of the TIP peptide (TIP-B) was slightly
more effective in in vitro tests [15,16], but it is unknown,
if this effect is transferable to an in vivo setting. Follow-
ing a study that demonstrated oedema-attenuating prop-
erties of TIP peptide inhalation in a porcine model [14]
we examined two hypotheses: (1) Single doses of two
synthetic peptide variants (SD-TIP-A, SD-TIP-B) show
comparable effects on lung water content and the pul-
monary function. (2) Repetitive application of TIP-A
(RD-TIP-A) further reduces lung water content and im-
proves gas exchange in comparison to a single dose.
Methods
Following approval of the state and institutional animal
care committee (Landesuntersuchungsamt Rheinland-
Pfalz, Koblenz, Germany; 23 177–07/G 09-1-045) 21
healthy juvenile pigs (24–27 kg) were examined in a ran-
domised, investigator-blinded setting.
Anaesthesia and instrumentation
The animals were sedated by an intramuscular injection
of midazolam and ketamine. General anaesthesia was in-
duced and maintained by intravenous administration of
propofol (Fresenius Kabi, Bad Homburg, Germany;
4 mg kg−1 followed by 8–12 mg kg−1 h−1) and fentanyl
(Janssen-Cilag, Neuss, Germany; 4 μg kg−1 followed by
0.1-0.2 mg h−1). Endotracheal intubation was performed
and pressure-controlled ventilation was initiated: tidal
volume 10 ml kg−1, positive end-expiratory pressure
(PEEP) 5 cmH2O, fraction of inspired oxygen (FiO2) 0.3-
0.4 and respiratory rate targeted to achieve normocapnia.
Extended haemodynamic monitoring was established
surgically: a pulmonary artery catheter, an arterial line
for blood pressure monitoring, a central venous line and
a pulse contour cardiac output catheter (PiCCO, Pulsion
Medical, Munich, Germany). Following the instrumenta-
tion a fluid optimisation routine consisting of 50 ml of
hydroxyethyl starch (130/0.4, Volulyte, Fresenius Kabi,
Bad Homburg, Germany) was conducted. All animals
received a background infusion of balanced electrolyte
solution (Sterofundin, B.Braun, Melsungen, Germany,
5 ml kg−1 h−1).Lung injury model
Lung injury was induced by bronchoalveolar lavage
followed by a constant, injurious ventilation mode:
pressure-controlled ventilation, tidal volume 10 ml kg−1,
PEEP 0 cmH2O, FiO2 1.0, respiratory rate 25–35 min
−1
targeted to a carbon dioxide level < 8 kPa. The broncho-
alveolar lavage was performed as previously described
[14]. The amount of instilled and recovered fluid was re-
corded to determine the fluid intake by lavage. Lavage
procedures were repeated until a ratio of arterial partial
pressure of oxygen (PaO2) and FiO2 ≤ 200 mmHg was
achieved and maintained for 45 minutes. Afterwards
baseline measurements were taken.
Protocol and drug administration
The TNF-α derived TIP peptides A and B (AP301 and
AP318, APEPTICO, Vienna, Austria) were delivered by
the manufacturer as lyophilisate at – 20° Celsius. Every
single dosage (1 mg kg−1) was dissolved at the day of ap-
plication in 5 ml water for injection, which resulted in a
transparent, non-discriminable fluid for inhalative appli-
cation. We used a commercially available, vibrating-plate
nebulizer (Aeroneb ProX, Aerogen, Galway, Ireland) that
was previously bench tested for TIP peptide inhalation
by APEPTICO. Randomisation and preparation of the
peptides were conducted by a non-participant for blinded
administration:
(1)SD-TIP-A group (n = 7; 1 mg kg−1 AP301 at 0 h,
vehicle at 3 h).
(2)RD-TIP-A group (n = 7; 1 mg kg−1 AP301 at 0 h
and 3 h).
(3)SD-TIP-B group (n = 7; 1 mg kg−1 AP318 at 0 h,
vehicle at 3 h).
Measured parameters
The animals were monitored for six hours after the first
TIP nebulisation. Spirometry, gas exchange and haemo-
dynamics were continuously monitored. The ventilation/
perfusion-distribution (V/Q) was determined as percent-
age of cardiac output by micropore membrane inlet
mass spectrometry - multiple inert gas elimination tech-
nique (MMIMS-MIGET, Oscillogy LLC, Folsom, USA)
according to a previously reported routine [17]. Devel-
opment of pulmonary oedema was assessed by the trans-
pulmonary thermodilution-derived extravascular lung
water index (EVLWI [ml kg−1]; PiCCO, Pulsion Medical,
Munich, Germany) and post-mortem wet/dry ratio
(W/D). The alveolar fluid clearance (AFC [%]) was cal-
culated as reported by Garcia-Delgado and co-workers
[18] with a modification that uses the amount of non-
recovered lavage fluid as reference: (EVLWBaseline [ml] –
EVLW6h [ml]) × 100/non-recovered lavage fluid [ml]. At
the end of the experiment the animals were killed in
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fol (200 mg) and potassium chloride (40 mval). The lung
was removed en-bloc after thoracotomy and assessed by
a lung injury score based on haemorrhage und conges-
tion of the lung surface [19]. The complete lung surface
was divided in four ventral and four dorsal segments
(each upper/lower right, upper/lower left) and each seg-
ment was scored individually: 2 points for haemorrhage
and congestion > 50% of the surface, 1 point for < 50%, 0
points for no or minimal, which results in a maximum
score value of 16 points. Afterwards the exsanguinated
left lung was weighted, sliced and dried for determin-
ation of the W/D ratio.
Statistical analysis
Data are expressed as median and interquartile range
(IQR). According to the two predefined hypotheses com-
parisons were only drawn SD- versus RD-TIP-A and
SD-TIP-A versus SD-TIP-B. Repetitively measured pa-
rameters (ARDS baseline, three and six hours) were ana-
lysed by Friedman Analysis of Variance and SNK-Test
for multiple comparisons. For non-recurring parameters
the Mann–Whitney-U-Test was used. P-values < 0.05
were regarded as significant. Additionally, we conductedTable 1 Additional parameters and MMIMS-MIGET-derived V/
SD-TIP-A RD-TIP-A
Parameter Baseline 3 h 6 h Baseline
AaDO2 [kPa] 64.7 (4.3) 50.4 (10.3) 49.6 (8.8) 66.4 (6.3)
PaCO2 [kPa] 6.7 (1.0) 5.1 (2.3) 5.5 (0.7) 7.5 (2.5)
Shunt [%] 35 (7) 20 (2) 25 (7) 28 (8)
Low V/Q [%] 0 (2) 6 (15) 0 (3) 3 (6)
Normal V/Q [%] 62 (8) 70 (11) 72 (5) 67 (6)
High V/Q [%] 0.7 (0.2) 0.6 (0.3) 0.6 (0.9) 0.7 (0.8)
Vt [ml kg
−1] 9.8 (0.2) 10.1 (0.5) 9.9 (0.6) 10.2 (0.6)
Ppeak [cmH2O] 20 (4) 20 (4) 19 (5) 20 (6)
PEEP [cmH2O] 0.5 (0.1) 0.6 (0.7) 0.6 (0.2) 0.5 (0.2)
RR [min−1] 30 (4) 28 (5) 30 (5) 30 (4)
Cdyn [ml mbar
−1] 13 (3) 13 (3) 13 (4) 13(3)
Raw [mbar s l
−1] 8 (1) 8 (2) 8 (1) 8 (2)
MAP [mmHg] 100 (6) 93 (15) 87 (19) 102 (25)
MPAP [mmHg] 30 (5) 27 (4) 26 (6) 35 (6)
CO [l min−1] 3.8 (1.0) 3.5 (1.2) 3.3 (0.9) 3.8 (0.9)
PVR [dyn s cm−5] 423 (127) 384 (152) 432 (368) 362 (122)
HR [min−1] 100 (25) 97 (18) 96 (23) 109 (36)
PCWP [mmHg] 13 (5) 12 (6) 13 (7) 14 (5)
CVP [mmHg] 11 (1) 10 (2) 10 (2) 12 (2)
Data are expressed as median (IQR). No relevant intergroup differences were found
oxygen; Shunt and V/Q measured by MMIMS-MIGET; Vt: Tidal volume; Ppeak: Peak ins
FiO2: Fraction of inspired oxygen; Cdyn: Dynamic compliance; Raw: Airway resistance;
Cardiac output; PVR: Pulmonary vascular resistance; HR: Heart rate; PCWP: Pulmonara post-hoc comparison of the EVLWI values and their
changes over time to a previously published vehicle
group [14] from the identical ARDS model. The statis-




All three groups received a comparable number of lav-
age procedures (SD-TIP-A: 3 (1); RD-TIP-A: 3 (2); SD-TIP-
B: 3 (1)). The amounts of fluid that were not recovered
from the lungs during lavage were 360 (155) ml (SD-TIP-
A), 320 (105) ml (RD-TIP-A), and 350 (115) ml (SD-TIP-
B). The small differences were not statistically significant.
The ARDS baseline data are summarized in Table 1.
Effect upon lung water content
Figure 1 shows the assessment of the lung water content.
The W/D ratio yields a significantly lower value of 5.3
(1.2) in the RD-TIP-A-group, while the median values
are 6.4 (1.0) in the SD-TIP-A-group and 6.4 (1.1) in the
SD-TIP-B-group. In all three groups the EVLWI signifi-
cantly decreases over six hours. The main reduction oc-
curs after the first TIP inhalation in all groups. Only theQ over six hours
SD-TIP-B
3 h 6 h Baseline 3 h 6 h
50.9 (20.3) 45.1 (17.5) 71.3 (11.5) 52.4 (14.0) 42.5 (14.3)
6.5 (0.5) 6.0 (0.8) 7.2 (1.0) 6.1 (0.7) 5.7 (0.5)
20 (3) 19 (9) 33 (15) 19 (7) 20 (6)
0.1 (7.5) 0 (0) 0 (0) 5 (15) 0 (0)
74 (13) 79 (8) 65 (11) 72 (17) 79 (6)
0.7 (0.4) 1.0 (0.8) 0.6 (1.1) 0.7 (0.8) 0.5 (1.5)
10.3 (0.7) 10.1 (0.5) 9.7 (0.2) 9.9 (0.6) 9.8 (0.8)
20 (11) 19 (8) 19 (4) 23 (8) 19 (7)
0.6 (0.6) 0.6 (0.5) 0.6 (0.2) 0.6 (0.3) 0.6 (0.3)
30 (4) 30 (3) 30 (6) 30 (3) 29 (5)
13 (4) 13 (4) 14 (3) 13 (4) 11 (5)
9 (3) 9 (3) 7 (1) 7 (2) 8 (2)
92 (14) 91 (11) 89 (11) 85 (18) 80 (15)
31 (5) 30 (7) 31 (7) 29 (12) 26 (14)
3.6 (0.7) 3.5 (0.5) 3.7 (1.2) 3.6 (0.6) 3.3 (0.9)
395 (137) 436 (120) 392 (199) 333 (252) 411 (355)
92 (39) 96 (36) 114 (27) 100 (33) 100 (23)
13 (4) 13 (6) 12 (2) 12 (5) 12 (5)
11 (4) 10 (4) 10 (1) 10 (1) 10 (1)
. AaDO2: Alveolar-arterial oxygen gradient; PaCO2: Arterial partial pressure of
piratory pressure; PEEP: Positive end-expiratory pressure; RR: Respiratory rate;
MAP: Mean arterial pressure; MPAP: Mean pulmonary arterial pressure; CO:
y capillary wedge pressure; CVP: Central venous pressure.
Figure 1 Assessment of the lung water content. The figure shows the thermodilution-derived extravascular lung water index (EVLWI), the
EVLWI changes over time (delta EVLWI), the calculated alveolar fluid clearance (AFC) over six hours, and the post-mortem gravimetric wet/dry (W/D)
ratio of the lung. Bars represent median (IQR). * indicate P < 0.05 versus the baseline or 3 h-value, # indicates P < 0.05 in the intergroup comparison.
According to the study’s hypotheses no comparisons between RD-TIP-A and SD-TIP-B were drawn.
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hours 3–6. At six hours a significant difference was
found between SD- and RD-TIP-A. But the corre-
sponding AFC and overall EVLWI changes over time
((Δ EVLWI) [ml kg−1]; RD-TIP-A: 4 (2); SD-TIP-A: 4 (1);
SD-TIP-B: 3 (1)) did not differ between the groups. The
post-hoc comparison to a previous control group (EVL-
WIBaseline 17 (5), EVLWI5h 16 (2), Δ EVLWI 1 (2); from
[14]) demonstrates a significantly lower absolute and
higher Δ EVLWI in all three TIP groups over five hours
(SD-TIP-A: EVLWI5h 14 (2), P = 0.040; RD-TIP-A EVL-
WI5h 12 (3), P = 0.001; SD-TIP-B: EVLWI5h 14 (3), P =
0.019) without differences at baseline.
Influence on oxygenation and ventilation-/perfusion-
distribution
The PaO2/FiO2 ratio considerably increased over six
hours in all three groups (Figure 2), which mainly oc-
curred within the hours 1–3. The three groups did not
differ at any time point. The MMIMS-MIGET derived
V/Q is summarized in Table 1 and Figure 3. In all
groups the normal V/Q fraction recovered over sixhours (each P < 0.05), which was caused by a decrease of
the combined shunt and low V/Q fraction.
Haemorrhage/congestion scoring and additional
parameters
The score values are 8 (3) in the SD-TIP-A-group, 8 (2)
in the RD-TIP-A-group, and 8 (3) in the SD-TIP-B-group
(Figure 4). Table 1 summarizes the monitored parameters
during the observation period. Neither haemodynamic in-
stability occurred nor was vasopressor support required.
Respiratory parameters and mechanics showed no rele-
vant differences.
Discussion
The present experimental study features two main find-
ings: (1) an only small further attenuation of pulmonary
oedema due to repeated TIP peptide inhalation in com-
parison to a single dose in a pre-validated porcine model
and (2) no differences in comparison of two single-
dosed TIP peptide versions (TIP-A and TIP–B) with
respect to lung water content, gas exchange and V/Q
distribution.
Figure 2 Time course of the PaO2/FiO2 quotient in all three groups. Bars represent median (IQR). * indicate P < 0.05 vs. baseline value. The
three groups do not differ significantly at any time point (P > 0.05).
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The early course of ARDS is characterized by pulmonary
fluid accumulation, reduction of lung compliance and
impaired gas exchange. Several experimental models can
be used to simulate distinct pathophysiologic compo-
nents of ARDS, though none mimics the entire pattern
of human ARDS. Repetitive saline lung lavage depletes
surfactant, but causes only mild structural damage of the
alveolar epithelium and low-grade injury of the alveolar-
capillary unit [20-22]. Repetitive lavage alone hardly
mimics the full pattern of ARDS. The combination withFigure 3 Normal ventilation/perfusion-distribution by MMIMS-MIGET
baseline value. No intergroup differences occurr (P > 0.05).an injurious ventilation mode, however, should induce
ongoing epithelial barrier damage and is propagated to
be more similar to human ARDS [20,23]. However, stan-
dardized protocols to achieve this are lacking. We chose
a mild combination of lavage-induced lung injury and
injurious ventilation (tidal volume 10 ml kg−1, PEEP 0
cmH2O): this approach warrants a relatively constant
state of gas exchange impairment and oedema without
further therapy [14]. The main rationale is that the ap-
ical side of the alveolar epithelium represents the TIP
peptide’s primary target [11]. The peptide’s impact uponafter six hours. Bars represent median (IQR). * indicate P < 0.05 vs.
Figure 4 Results of the post-mortem haemorrhage/congestion scoring. Bars represent median (IQR). The data show no intergroup differences
(P > 0.05).
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limited through a sustained epithelial necrosis and its
deposition only in ventilated areas [24].
The lavage procedure also leads to alveolar flooding
and pulmonary fluid accumulation (in the present study
about 300 ml). Vadasz and co-workers induced lung in-
jury and alveolar flooding in isolated ventilated and per-
fused rabbit lungs by an elevation of pulmonary venous
pressure or endo-/exotoxin administration [12]. They
demonstrated that single doses of a TIP peptide reduced
vascular permeability and increased the absorption of
intra-alveolar fluid. Similar results were found in an
ex vivo flooded rat lung model [10].Comparison of TIP-A and B
The TIP peptide AP301 stimulates the sodium influx in
human A549 cells and type II alveolar cells of several
animal species, which creates an osmotic gradient from
the alveoli to the interstitium. In porcine cell layers an
approximately 16-fold increase of sodium incurrent oc-
curred within fifteen minutes after TIP peptide applica-
tion [25]. Several synthetic peptides mimicking the
lectin-like domain of TNF-α activate epithelial sodium
channels, which were identified as the key structures tar-
geted by TIP peptides [15]. TIP-B was slightly more ef-
fective in in vitro experiments [15,16]. But we detected
no relevant differences regarding gas exchange and lung
water content between the two TIP peptide versions
in vivo. Prior to this the significant advantage of TIP-A
over placebo was demonstrated in the identical ARDS
model [14]: a post-hoc comparison to this study’s control
group shows a significant EVLWI reduction for SD-TIP-
A and SD-TIP-B. Beneficial effects on gas exchangein vivo were also shown in a rat lung-transplantation
model [11]. Our first hypothesis was therefore approved.Repetitive dosage
The time courses following a single TIP dose were in
line with the prior report. In contrast, the repetitive ap-
plication of TIP-A led to a considerably lower W/D ratio
than the single dose and an only small but further re-
duction of the EVLWI, whereas the Δ EVLWI and de-
rived AFC did not differ significantly between SD- and
RD-TIP-A. Our overall AFC was lower than reported in
healthy pigs (around 50% over four hours without PEEP
[18]), which fits to the concept of impaired AFC in
ARDS. Though, the used formula does not consider, if
an injurious ventilation mode leads to ongoing oedema
formation. Another porcine ARDS model, however, dem-
onstrated considerably lower AFC rates [26]. The present
data imply that the impact of the TIP peptide on the lung
water content may be short-termed but traceable even
under sub-standard ventilation. However, pharmacologic
reduction of lung water content alone may not improve
outcome or mortality [27]. The recovery of lung function
in terms of oxygenation and V/Q was not intensified by
repetitive inhalation. Therefore our second hypothesis was
only partially confirmed: the observed, additional changes
of the lung water content are quite small and may not be
sufficient to cause amelioration of gas exchange. The ma-
jority of the effect is definitely attributed to the first TIP
inhalation in all groups (Figure 1). In this context, it is
worth to note that the present study was not designed to
analyse synergistic effects with the current standard of
lung-protective ventilation. To some extent the present
model and ventilation mode will not restore healthy
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reflected by the considerable presence of haemorrhage
and congestion in all groups.
Implications of oedema reabsorption
The V/Q data suggest that the impaired oxygenation is
caused mainly by intrapulmonary shunt and low V/Q
units from collapsed or flooded alveoli. Similar results
were reported in two other porcine lavage models
[17,28]. Due to the ventilation mode without PEEP a
sustained recruitment of non-ventilated lung areas over
time is unlikely, which is consistent with the persisting
shunt fraction and the minimal presence of high V/Q
units indicating hyperinflation. The present study
describes two different effects of the TIP peptides:
optimization of the V/Q mismatch and reduced lung
water content. Recent studies characterised the correla-
tions between EVLWI, the amount of non-aerated lung
tissue, and V/Q distribution in pigs [29,30]. Based on
the present data we can hardly differentiate, if oedema
reduction and improved V/Q matching are associated or
occur merely simultaneous. Previous studies did not re-
port on systemic or haemodynamic effects of the TIP
peptide [11,31]. Hence, a relevant impact of the peptide
itself on pulmonary perfusion is unlikely. The physio-
logical hypoxic pulmonary vasoconstriction, however, is
unaffected after lung lavage [32].
Recovery from ARDS requires reabsorption of the pul-
monary oedema and enabling of the epithelial structures
to rest and recover [33]. Distribution of pulmonary
oedema in ARDS is not homogeneous. The injured lung
is therefore widely inhomogeneous in its response to
mechanical ventilation or recruitment even during lung
protective ventilation [34,35]. This can result in in-
creased cyclic stretch and strain of the lung tissue, which
is associated with vascular permeability and inflamma-
tion. Patients suffering from a high-grade AFC impair-
ment in early ARDS have significantly higher mortality
rates [4]. The present model implies a sustained effect of
the TIP peptide on the initial alveolar flooding, which, in
the absence of recruitment or PEEP [18], is consistent
with a resolution of oedema fluid. Hence, an early en-
hancement of the alveolar fluid clearance may not only
reduce the lung water content but also lead to more
homogenous lung tissue. This could positively affect dis-
tribution of mechanical ventilation and stress within the
lung tissue.
Limitations
TIP peptide inhalation currently lacks an established
dose-effect correlation in vivo. Therefore, we extrapolated
the applied dosages of 1 mg kg−1 from previous small ani-
mal and ex vivo models (approximately 0.5 mg kg−1,
[10,11]). Subsequently, this dosage was effective in aprevious placebo-controlled porcine study [14]. Accord-
ingly we passed on an additional placebo group that would
merely repeat this previous work without an impact on
this study’s two hypotheses. However, we performed a
post-hoc comparison of the present study’s EVLWI data
to this previous control group. The W/D ratio was calcu-
lated in a previously reported manner without correction
for pulmonary blood content in exsanguinated pigs [22],
which should though primarily reflect alveolar oedema
[36]. The majority of the TIP peptide’s effect occurred
within three hours after application. A persisting influence
of the TIP peptide upon intrapulmonary inflammation
was assumed in a recent study [11]. Accumulation of neu-
trophil granulocytes and generation of reactive oxygen
species were significantly attenuated by a TIP peptide
[11,13]. Potential anti-inflammatory effects were not ana-
lysed, but may be equalized by the ongoing mechanical
stress resulting from an injurious ventilation mode.
Altogether, the present study was designed to characterise
acute effects in a relatively mild ARDS and not to provide
long-term outcome data, which rather is the domain of
early clinical studies.Conclusions
In a model of lung lavage followed by constant injurious
ventilation the repetitive inhalation of a TNF-α derived
TIP peptide may lead to a small additional decrease of
lung water content. Though, this repetitive dosage did
not improve gas exchange or attenuate pulmonary
haemorrhage and congestion in comparison to a single
dose. Inhaled TIP peptides induce a clearance of pul-
monary oedema and improve the ventilation/perfusion-
distribution. Two alternate versions of the TIP peptide
showed interchangeable characteristics in vivo.Abbreviations
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